Analysts Set Henry Schein, Inc. (NASDAQ:HSIC) Price Target at $79.40

Henry Schein, Inc. (NASDAQ:HSICGet Free Report) has been given an average rating of “Moderate Buy” by the twelve brokerages that are currently covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $79.40.

HSIC has been the topic of several recent research reports. Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research report on Wednesday, November 6th. Evercore ISI raised their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and raised their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. Mizuho assumed coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th.

Check Out Our Latest Research Report on HSIC

Insider Transactions at Henry Schein

In related news, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.14% of the company’s stock.

Institutional Trading of Henry Schein

A number of hedge funds and other institutional investors have recently made changes to their positions in HSIC. Acadian Asset Management LLC raised its stake in shares of Henry Schein by 10.2% in the 2nd quarter. Acadian Asset Management LLC now owns 3,757 shares of the company’s stock valued at $240,000 after purchasing an additional 348 shares in the last quarter. Quest Partners LLC acquired a new stake in shares of Henry Schein during the 2nd quarter valued at approximately $177,000. Daiwa Securities Group Inc. lifted its stake in Henry Schein by 9.1% during the second quarter. Daiwa Securities Group Inc. now owns 14,040 shares of the company’s stock worth $900,000 after purchasing an additional 1,171 shares during the last quarter. Headlands Technologies LLC increased its stake in Henry Schein by 835.4% during the second quarter. Headlands Technologies LLC now owns 8,288 shares of the company’s stock valued at $531,000 after purchasing an additional 7,402 shares during the last quarter. Finally, Nuance Investments LLC raised its holdings in shares of Henry Schein by 6.2% during the second quarter. Nuance Investments LLC now owns 1,863,333 shares of the company’s stock worth $119,440,000 after purchasing an additional 108,143 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Up 1.5 %

Shares of HSIC stock opened at $70.70 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock’s fifty day moving average price is $72.14 and its 200 day moving average price is $70.47. Henry Schein has a 1-year low of $63.67 and a 1-year high of $82.63. The company has a market cap of $8.81 billion, a price-to-earnings ratio of 29.09, a price-to-earnings-growth ratio of 2.30 and a beta of 0.89.

Henry Schein (NASDAQ:HSICGet Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s revenue for the quarter was up .4% on a year-over-year basis. During the same period in the previous year, the business earned $1.32 EPS. On average, research analysts expect that Henry Schein will post 4.78 earnings per share for the current fiscal year.

Henry Schein Company Profile

(Get Free Report

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.